Table 2.
Index | Before therapy | After treatment | t | P |
---|---|---|---|---|
WBC (109/L) | 7.22±2.24 | 6.59±2.73 | 2.880 | 0.005 |
HGB (g/L) | 130.53±18.67 | 119.87±18.67 | 7.127 | 0.000 |
PLT (109/L) | 153.11±85.94 | 239.03±85.38 | 2.052 | 0.042 |
ANC (109/L) | 4.93±1.96 | 4.39±2.65 | 2.494 | 0.014 |
ALC (109/L) | 1.51±0.56 | 1.45±0.55 | 1.196 | 0.234 |
AMC (109/L) | 0.54±0.24 | 0.56±0.25 | -0.881 | 0.380 |
NLR (%) | 3.77±2.27 | 3.60±2.86 | 0.604 | 0.547 |
PLR (%) | 192.55±110.73 | 183.18±89.59 | 0.908 | 0.365 |
LMR (%) | 3.38±2.61 | 3.03±1.68 | 1.436 | 0.153 |
ALB (g/L) | 36.56±4.53 | 36.81±5.48 | -0.500 | 0.618 |
TC (mmol/L) | 4.23±0.86 | 4.44±1.02 | -2.676 | 0.008 |
TG (mmol/L) | 1.29±0.71 | 1.43±0.72 | -1.996 | 0.048 |
HDL (mmol/L) | 1.19±0.31 | 1.26±0.39 | -2.349 | 0.020 |
LDL (mmol/L) | 2.79±0.71 | 2.87±0.84 | -1.408 | 0.162 |
APO-A1 (g/L) | 1.17±0.27 | 1.19±0.29 | -0.628 | 0.531 |
APO-B (g/L) | 0.85±0.22 | 0.88±0.27 | -1.889 | 0.061 |
Notes: WBC, white blood cell; HGB, hemoglobin; PLT, platelets; ANC, absolute neutrophil count; ALC, lymphocyte count; AMC, monocyte count; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; LMR, lymphocyte/monocyte ratio; ALB, albumin; TC, cholesterol; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; APO-A1, apolipoprotein A1; APO-B, apolipoprotein B.